Rapt therapeutics stock news
The Company is also pursuing a range of targets that are in the discovery stage of development. RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. RAPT 36.62 2.08 (6.02) Post-Market 0.00 (0.00) 1,907. Rapt Therapeutics Inc (RAPT) Company Description RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. RAPT Therapeutics NASDAQ Updated 9:09 PM. (RAPT) are surging over 50 on Monday morning after the company reported positive topline results from early stage study for.
RAPT THERAPEUTICS STOCK NEWS DRIVERS
Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT RAPT Therapeutics Stock Price and Discussion Stocktwits. (RTTNews) - Shares of RAPT Therapeutics, Inc. The company has a market cap of 979.75 million, a P/E ratio of -13.59 and a beta of 0.15. RAPT Therapeutics has a 12-month low of 14.89 and a 12-month high of 43.26. The stock has a fifty day moving average price of 34.68 and a 200 day moving average price of 33.46. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. SEC Filing - Quarterly Report (10-Q) AugRAPT Therapeutics raises 125M via equity offering RAPT, SIOX, ACHL and PTGX among after-hours movers RAPT Therapeutics. Shares of NASDAQ RAPT opened at 33.16 on Wednesday. Sector Professional, Scientific, and Technical Services.Industry Research and Development in Biotechnology.